We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.48B
AUM Growth
+$152M
Cap. Flow
+$58.2M
Cap. Flow %
2.35%
Top 10 Hldgs %
26.38%
Holding
291
New
33
Increased
134
Reduced
93
Closed
18

Top Buys

Rank Stock Value
1
ZD icon
Ziff Davis
ZD
+$32.7M
2
SIMO icon
Silicon Motion
SIMO
+$15.7M
3
FATE icon
Fate Therapeutics
FATE
+$11.4M
4
KPTI icon
Karyopharm Therapeutics
KPTI
+$11.3M
5
EEFT icon
Euronet Worldwide
EEFT
+$10.7M

Top Sells

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$28.2M
2
IMMU
Immunomedics Inc
IMMU
+$16.9M
3
AJRD
Aerojet Rocketdyne Holdings
AJRD
+$8.48M
4
ONTO icon
Onto Innovation
ONTO
+$7.79M
5
LSCC icon
Lattice Semiconductor
LSCC
+$6.59M

Sector Composition

Rank Sector Weight
1 Healthcare 24.68%
2 Technology 21.94%
3 Industrials 17.48%
4 Consumer Discretionary 13.63%
5 Communication Services 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
251
Eli Lilly
LLY
$1.09T
$369K 0.01%
2,490
– –
BRK.A icon
252
Berkshire Hathaway Class A
BRK.A
$1.12T
$320K 0.01%
1
– –
AMZN icon
253
Amazon
AMZN
$2.94T
$302K 0.01%
+1,920
New +$303K
MSFT icon
254
Microsoft
MSFT
$3.73T
$294K 0.01%
1,400
– –
LAD icon
255
Lithia Motors
LAD
$8.37B
$292K 0.01%
+1,282
New +$288K
IWO icon
256
iShares Russell 2000 Growth ETF
IWO
$14.9B
$291K 0.01%
1,313
-408
-24% -$89.3K
WDFC icon
257
WD-40
WDFC
$3.12B
$274K 0.01%
1,450
– –
AMN icon
258
AMN Healthcare
AMN
$1.33B
$234K 0.01%
+3,998
New +$210K
BMY icon
259
Bristol-Myers Squibb
BMY
$130B
$233K 0.01%
3,870
-338
-8% -$20.3K
ENOV icon
260
Enovis
ENOV
$1.43B
$227K 0.01%
+4,205
New +$231K
SBUX icon
261
Starbucks
SBUX
$121B
$226K 0.01%
+2,633
New +$210K
CTRE icon
262
CareTrust REIT
CTRE
$9.21B
$224K 0.01%
+12,582
New +$229K
JPM icon
263
JPMorgan Chase
JPM
$959B
$217K 0.01%
2,249
– –
THO icon
264
Thor Industries
THO
$4.19B
$211K 0.01%
+2,211
New +$229K
MLKN icon
265
MillerKnoll
MLKN
$1.64B
$208K 0.01%
+6,896
New +$171K
CHNG
266
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$179K 0.01%
12,347
-3,051
-20% -$38.8K
LXP icon
267
LXP Industrial Trust
LXP
$3.58B
$178K 0.01%
+3,411
New +$189K
FNB icon
268
FNB Corp
FNB
$6.77B
$147K 0.01%
+21,714
New +$159K
PDM
269
Piedmont Realty Trust
PDM
$1.16B
$142K 0.01%
+10,487
New +$162K
HOPE icon
270
Hope Bancorp
HOPE
$1.8B
$130K 0.01%
+17,075
New +$143K
BRKL
271
DELISTED
Brookline Bancorp
BRKL
$111K ﹤0.01%
+12,879
New +$122K
FHN icon
272
First Horizon
FHN
$12B
$97K ﹤0.01%
+10,302
New +$96.8K
NMRK icon
273
Newmark Group
NMRK
$2.6B
$69K ﹤0.01%
+15,971
New +$69.1K
ANIP icon
274
ANI Pharmaceuticals
ANIP
$1.73B
– –
-27,526
Closed -$890K
BGSF icon
275
BGSF Inc
BGSF
$58.3M
– –
-74,761
Closed -$846K
8 9 10
11
12

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Rice Hall James & Associates held 291 positions worth $2.48B, up 6.5% from $2.33B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2020 filing shows 33 new, 134 increased, 93 reduced and 18 closed positions. Its largest new stake was Fate Therapeutics: 326,844 shares worth $13.1M. The largest sale was Trade Desk, an estimated $28.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2020 buy was Fate Therapeutics: 326,844 shares worth $13.1M.
  • Rice Hall James & Associates added most to Ziff Davis in Q3 2020, an estimated $32.7M increase.
  • Rice Hall James & Associates's biggest Q3 2020 reduction was Trade Desk, cutting an estimated $28.2M.
  • Rice Hall James & Associates fully exited Aerojet Rocketdyne Holdings in Q3 2020, selling an estimated $8.48M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $2.48B portfolio in Q3 2020.
  • Rice Hall James & Associates opened 33 new positions and closed 18 in Q3 2020.
  • Rice Hall James & Associates's portfolio value rose 6.5% quarter-over-quarter to $2.48B.

Based on Rice Hall James & Associates's 13F filing for Q3 2020, filed 16 Nov 2020.